cri-one
Contents
100%
Your journey

Cessation Alchemy Data (56-cessation-database)

Inventory item: 8506 | SKU: 2087 | Line: Blueprints

Page: https://cri-one.com/56-cessation-database.html

Owner and author: Christopher Gabriel Brown (CRI-ONE)

Record date: 8 October 2026

Approved public wording item: medical and regulatory wording follows the descriptions-public text for item 8506.

1. The Record in Brief

Cessation Alchemy Data is a structured research data package: six Universal Cessation Forces (UCF-1 to UCF-6) applied across nine substance and dual-diagnosis categories, with eight clinical-research modules, a query tool and a seven-recipe bridge to the Chemical Cooker (Project 16) (D:/special/56-cessation-database/README.md; cooker_compat/recipes/MANIFEST.json). Its own files state it plainly: "Computational research findings — not medical advice, not clinically tested, not FDA-approved" (D:/special/_inventory/descriptions-public/8506.md). The earliest dated disclosures of its subject are the owner's numbered depositions 133 and 373 (buyinvent.com catalog, marked copyright 2017) and 943 and 1018 (printed in Invent Depositions, ISBN 978-1-979767-89-7, first shipped 24 November 2017). The package is dated 3 July 2026 and was publicly listed on the cri-one.com store on 4 July 2026. The USPTO record holds dated portfolio filings; it names no application for this product, and the product stands on First Art. The package's principal text, data and code files and its display figures carry the owner's dated copyright notice.

2. Proprietary - What Is Owned and How It Is Held

The package folder D:/special/56-cessation-database holds 54 files in these families (counted on disk, 8 October 2026):

  • Research database: cessation_pharma_database.json (136,322 bytes of structured JSON on disk). Its own statistics block records 6 forces, 9 cessation targets, 28 non-chemical reward activities, 30 evidence citations, 14 nutrient toxicology entries, 19 drug-test substances indexed and 10 resolution-engine output fields.
  • Code: 4 Python files (cessation_query.py, cooker_compat/cessation_ucf_to_recipe.py, push_to_store.py, figures/generate_pngs.py).
  • Recipe bridge: 7 JSON recipes, 7 G-code files and a recipe MANIFEST.json in cooker_compat/recipes/.
  • Documentation: 8 Markdown files and 7 HTML files (README, BUYER_PITCH, LICENSING, HANDOFF_BLURB, WEB_DESCRIPTION, store cards, table of contents).
  • Pictures: 9 PNG and 3 SVG figures.
  • Inventor reference: the master IP register 1 light trigger.txt (1,769 lines, SHA-256 identical to D:/special/82-alchemy-calc-two/1 light trigger.txt) plus contact and note files.

Sole ownership. Every manifest, database header and licence file names one author, Christopher Gabriel Brown. MANIFEST.json records the stance "IP RETAINED by CGB." No assignment is of record.

What a buyer receives. The owner's own licence text grants a tiered use right and conveys no ownership: "No tier conveys a patent license, IP license, exclusive rights, or ownership transfer" (LICENSING.md). The purchase term at https://cri-one.com/terms reads "When you buy, you buy the use of that blueprint only." and must be accepted at checkout; the item page repeats it beside the Buy button.

Secrecy measures of record. The full package is delivered only to paying buyers by private download link; the delivery file of record is 56-cessation-database__2026-09-04.zip (D:/special/crione-static/delivery-v2/product_deliverables.csv). The mutual NDA is published at https://cri-one.com/nda/ and quoted in delivery emails. The public item page carries only the description. These are the reasonable secrecy measures of record under 18 U.S.C. 1839(3) for the undisclosed database, code and recipe files.

3. First Art - The Earliest Dated Disclosure

DateRecordWhat it disclosesSource
2017 (mark)Deposition 133, buyinvent.com catalogMeasuring changes at dopamine, serotonin, adrenaline and histamine receptor sitesentries-clean.csv
2017 (mark)Deposition 373, buyinvent.com catalogToxicity and valence testing for substance abuse cessation aidsentries-clean.csv
2017-11-24Deposition 1018, Invent Depositions p. 266Restoring balance after narcotic-induced chemical imbalanceentries-index.csv
2017-11-24Deposition 943, Invent Depositions p. 631Cannabis cessation by a chemistry-balance techniqueentries-index.csv
2026-07-03Package version dateSix-force, nine-category cessation research substrateMANIFEST.json
2026-07-04Public store listing CEASE-56Cessation Alchemy Data, 6 forces x 9 protocolsexport_catalog_product_20260713_064229.csv

Deposition anchors (master IP register D:/special/82-alchemy-calc-two/1 light trigger.txt; register DEPOSITIONS_B, id 8506):

  • Deposition 373 (register line 1061, direct; 2017 catalog): "toxic and valance testing to include but not limited to cancer and diseases like alzheimer's and substance abuse cessation aids."
  • Deposition 943 (register line 1694, direct; printed book page 631): "marijuana cessation and the caffeine pill using a positive for a past negative by tolerances and over balanced technique of chemistry"
  • Deposition 1018 (register line 23, ancestor; printed book page 266): "mental illness derived from narcotics including lsd is the known cause of many induced chemical imbalances"
  • Deposition 133 (register line 369, ancestor; 2017 catalog): "diagnose changes at dopa mine serotonin adrenaline and histamine receptor sites in the central nervous system"

Depositions 943 and 1018 were printed under the owner's name in Invent Depositions, first shipped 24 November 2017. Depositions 133 and 373 stand in the buyinvent.com catalog under the owner's name, each carrying the mark "copyright © 2017 chris g brown". Under 35 U.S.C. 102(a)(1), a printed publication before a filing date is prior art against that filing. The printed 2017 depositions and the 4 July 2026 public listing therefore stand against every later filer on the subject matter they disclose. A challenger must produce a dated record earlier than these, disclosing the same combination of six cessation forces across nine categories with the withdrawal index and resolution engine. None is of record.

Prior Art Considered and Distinguished

The package holds no search file of its own. The site provenance record keyed to SKU 2087 (crione-provenance.json) lists six portfolio-level references; the register titles are used here.

ReferenceTitle as recordedDistinction
US 4,775,876Photon recycling light emitting diodeLED photon recycling; no cessation data, forces or protocols
US 2012/0305059 A1Photon recycling in an optoelectronic deviceOptoelectronic device art; different subject matter
US 2010/0183919 A1Quantum dot ultracapacitor and electron batteryEnergy storage; no cessation research content
US 6,175,719 B1Multi-Spot-Beam SatelliteSatellite payload; different subject matter
US 7,418,236 B2Extraterrestrial Communications SystemsCommunications systems; different subject matter
US 11,258,379 B2Quantum Noise Power DevicesEnergy harvesting devices; different subject matter

None of the six addresses substance cessation, receptor-recovery timelines or a cessation data compilation. The product's documented structure (cessation_pharma_database.json) shares no element with them.

4. First to File - The USPTO Record

U.S. ApplicationFiledStatus of recordWhat it covers for this productSource
62/375,1152016-08-15Abandoned 2017-07-24Portfolio provisional titled "Depositions"; not mapped to this productUSPTO_REGISTER.json
19/540,4532026-02-13PendingListed for SKU 2087 on the site provenance record; its recorded title does not name this productcrione-provenance.json; USPTO_REGISTER.json
19/555,5252026-03-03PendingCompanion Projects 22 (Brain Chemistry) and 33 (Health Recovery); not this productUSPTO_REGISTER.json
19/666,1852026-05-02PendingCompanion Projects 07 and 41; not this productUSPTO_REGISTER.json

The USPTO register records that no filing names 56-cessation-database (D:/Rebuttals/_registers/USPTO_REGISTER.md, row 8506). Application 62/375,115 is a USPTO-dated record of the owner's disclosure activity: the 15 August 2016 date-stamp stands; the provisional lapsed on 24 July 2017. The owner holds pending applications on the companion research projects the package cross-references. This product's priority rests on First Art: the 2017 depositions and the 4 July 2026 public listing are dated prior art against any later application on the same combination, by any filer.

5. First to Market - The Dated Public Offering

DateEventWhereSource
2026-07-04Store listing "Cessation Alchemy Data", SKU CEASE-56cri-one.com (old Magento store)D:/manager/export_catalog_product_20260713_064229.csv
2026-08-31Blueprint record 56-cessation-database, SKU 2087cri-one.com (old Magento store)D:/manager/_store/export_catalog_product_20260831_201548.csv
2026-09-01Record re-created; kept in the 2026-09-07 exportcri-one.com (old Magento store)D:/manager/export_catalog_product_20260907_110415.csv
2026-09-04Delivery file of record datedDelivery copiesD:/special/crione-static/delivery-v2/product_deliverables.csv
2026-10-08Item page live on the new static sitehttps://cri-one.com/56-cessation-database.htmlsite-inventory/inventory/item-8506/index.html
2026-10-08 05:06 UTCStripe card Buy button public (link created 04:56:21 UTC)Item pageD:/special/crione-static/delivery-v2/payment_links_ledger.live.json; FIRST_TO_MARKET_REGISTER.md

6. Copyright

Notice of record: the dated notice "Copyright (c) 2026 Christopher Gabriel Brown" appears in MANIFEST.json, LICENSING.md, README.md, cessation_pharma_database.json and the code files; the display figures cessation_symbol.svg and cessation_store_display.svg carry "Copyright (C) 2026 Christopher Gabriel Brown". The bundled IP register carries the deposition marks "copyright © 2017 chris g brown".

Works covered: the text of the README, licence, pitch and web descriptions; the data compilation in cessation_pharma_database.json; the Python source code; the JSON and G-code recipe files; and the 12 figures. Copyright arose on fixation (17 U.S.C. 102(a)). It protects this expression, not the cessation method or the force framework as ideas (17 U.S.C. 102(b)); method and structure are held by confidentiality and by First Art.

Registrations anchoring the corpus (all marked verified in D:/Rebuttals/_registers/COPYRIGHT_REGISTER.md): TX 7-491-093 invent cloud (effective 2010-10-01), TX 7-786-269 Invent Concepts (2013-09-02), TX 8-021-945 Invent Copyrights (2015-01-11), TX 8-251-642 cri-one (2015-12-17), TX 8-648-723 2018 (2018-09-10) and TX 9-504-677 estimated (2025-05-06), 19 verified registrations in all. Invent Depositions (2017) stands as a dated printed publication, ISBN 978-1-979767-89-7. Registration is the gateway to suit for U.S. works (17 U.S.C. 411(a)); a certificate made within five years of first publication is prima facie evidence of validity (17 U.S.C. 410(c)).

Human authorship. Protection covers the human-authored expression and the author's selection, coordination and arrangement (U.S. Copyright Office registration guidance, March 2023). The protectable core here is human-authored: the concept, the numbered depositions 133, 373, 943 and 1018 written by Christopher Gabriel Brown, and his selection, arrangement and direction of the package into six forces, nine categories and eight modules.

Notice practice. The dated notice on the principal files means an infringer with access to those copies cannot plead innocent infringement in mitigation of damages (17 U.S.C. 401(d)).

7. Firm Rebuttals

Challenge 1 - "Cessation research already exists; this is not original."

Rebuttal. The record shows the owner's dated cessation disclosures in 2017: depositions 373 and 943 name substance abuse cessation aids and cannabis cessation, and 133 and 1018 name the receptor and rebalancing principles (1 light trigger.txt, lines 1061, 1694, 369, 23). The six references on the provenance record for SKU 2087 address LEDs, energy storage and satellites. A challenger must produce a dated record disclosing the same six-force, nine-category combination with the withdrawal index and resolution engine before 4 July 2026. None is of record.

Challenge 2 - "Someone filed first."

Rebuttal. Under first-inventor-to-file, every application is dated by its own effective filing date, and 35 U.S.C. 102(a)(1) makes earlier public disclosures prior art against it. Depositions 943 and 1018 were printed and shipped on 24 November 2017 (entries-index.csv), and the product was publicly listed on 4 July 2026 (export_catalog_product_20260713_064229.csv). Any filing after those dates on the subject matter they disclose meets this record as prior art. The challenger must show a filing date earlier than those disclosures, on the same combination.

Challenge 3 - "No patent has issued, so there is nothing to protect."

Rebuttal. No CRI-ONE application has issued, and the owner claims none for this product. The package is held by three instruments that need no patent: copyright in its text, data, code and pictures (17 U.S.C. 102(a)); trade-secret protection of the undisclosed database and code under 18 U.S.C. 1839(3), with private delivery, the published NDA and the checkout term; and dated public disclosure that stands as prior art against later filers.

Challenge 4 - "It was published, so it is free to use."

Rebuttal. Publication of a description does not license the work. The public item page carries the description only; the database, code and recipes are delivered privately under the term "When you buy, you buy the use of that blueprint only." (https://cri-one.com/terms). The depositions remain the owner's copyright works under their 2017 marks. Their legal effect is defensive: they stand as prior art against every later filer on the same subject.

Challenge 5 - "AI made it, so there is no copyright."

Rebuttal. The package records AI assistance in assembly (cessation_pharma_database.json, field "generated_by"). Protection covers the human-authored expression and the author's selection, coordination and arrangement (U.S. Copyright Office registration guidance, March 2023). The human-authored core is of record: depositions 133, 373, 943 and 1018, written by Christopher Gabriel Brown and dated 2017, the force-and-category concept, and his selection, arrangement and direction of the package. That core carries his name and his 2017 marks.

Challenge 6 - "The dates can be faked."

Rebuttal. The dates rest on records the owner does not control. Invent Depositions carries ISBN 978-1-979767-89-7, and the CreateSpace label records first shipment on 24 November 2017 (D:/Rebuttals/_registers/COPYRIGHT_REGISTER.md). The Internet Archive holds third-party captures of buyinvent.com from 2014-03-05 and cri-one.com from 2011-01-28 (wayback_evidence.json). The USPTO date-stamped 62/375,115 on 15 August 2016. The Stripe ledger records the payment link at 2026-10-08T04:56:21Z. The SHA-256 fingerprints in Section 8 fix every cited file's content as of this record.

Challenge 7 - "This is a medical claim without FDA approval."

Rebuttal. It is a research IP record, and it makes no treatment claim. The approved public wording states: "Computational research findings — not medical advice, not clinically tested, not FDA-approved. Deliverables are R&D substrate for pharma-industry validation and clinical program design." (descriptions-public/8506.md). The buyer is an R&D organisation that runs its own validation; the Complete tier expressly excludes clinical-trial services (LICENSING.md).

Challenge 8 - "It is just an idea."

Rebuttal. The package is concrete and counted: a 136,322-byte structured database with its own statistics block, a working query tool, a recipe generator, 7 JSON recipes with 7 matching G-code files conformant to the Project 16 Chemical Cooker recipe schema, 12 figures and full documentation (MANIFEST.json; cooker_compat/recipes/MANIFEST.json). Delivery is a dated, hashed file of record (product_deliverables.csv).

Challenge 9 - "It is only public pharmacology collected in one place."

Rebuttal. The owner's own description labels the toxicology module's nutrient reference values as public-domain Dietary Reference Intakes (descriptions-public/8506.md). What the owner holds is the selection, coordination and arrangement: six forces mapped across nine categories, ten-domain withdrawal index, six lab panels and a resolution engine with 12 inputs and 10 outputs (cessation_pharma_database.json, statistics). That arrangement is the owner's expression and is held in confidence beyond the public description.

8. Evidence Index

#FileSHA-256 (first 16 hex)What it proves
1D:/special/56-cessation-database/README.md46bdd8b097202bcePackage content, forces, modules, author, date
2D:/special/56-cessation-database/LICENSING.md900464bebc5357d8Owner's licence grant; no IP transfer
3D:/special/56-cessation-database/MANIFEST.jsoneabb22f467df461bPackage date 2026-07-03, author, notice
4D:/special/56-cessation-database/cessation_pharma_database.json852b88b81a9d0b67The data compilation and its statistics
5D:/special/82-alchemy-calc-two/1 light trigger.txt2dcb359de3f1b56dDepositions 133, 373, 943, 1018 (identical copy in package)
6D:/manager/book-ocr-2017-invent-depositions/entries-index.csv9e72c4638df2ca6eBook pages 631 and 266 for depositions 943, 1018
7D:/manager/book-ocr-2017-invent-depositions/entries-clean.csvad3b87e885814dbb2017 catalog entries 133 and 373 with marks
8D:/special/_inventory/descriptions-public/8506.mda59b1fd69755177fApproved public wording and disclaimer
9D:/manager/export_catalog_product_20260713_064229.csv92850d62a851042bPublic store listing CEASE-56, 2026-07-04
10D:/special/crione-static/delivery-v2/product_deliverables.csvf365ff876c06d2bfPrivate delivery file of record
11D:/special/crione-static/delivery-v2/payment_links_ledger.live.json96abb64653254b86Payment link 2026-10-08T04:56:21Z
12D:/special/crione-static/site-inventory/inventory/item-8506/index.html0a3acda6fb99183cItem page and purchase term
13D:/manager/first-to-market/wayback_evidence.jsona0dde412013594b5Internet Archive first captures
14D:/special/_store/manager/_store/site-deploy-2026-09-23/archive-images-fix/crione-provenance.json4245280e5b3aea54Prior art and filing listed for SKU 2087
15D:/manager/_patent_copyright_text.txt347cf96622ef6761Certificate text of the TX registrations and USPTO papers

Full hash lines: D:/Rebuttals/_evidence/8506.sha256.

9. Notice Line

© 2017-2026 Christopher Gabriel Brown (CRI-ONE). All rights reserved.

This invention blueprint: Cessation Database · $500M.
cri-one.com/56-cessation-database.html
Also sold as part of Cri-One Health 2026 · $10.08B.
Payment is by bank transfer through Stripe.
Go to cart
Page 1 of 1
0% read